BioSpace News Archive

Pharm Country

BioIVT to Provide Rare Biosamples for the FNIH Biomarkers Consortium Neurodegenerative Disease Project

BioIVT is sourcing matched sets of cerebrospinal fluid, serum, and plasma from donors afflicted with ALS to further research of neurofilament in the blood as a biomarker for early stages of neurodegeneration.

May 16, 2022
·
4 min read
Business

Promontory Therapeutics Appoints Johan Baeck, MD, as Executive Vice President and Chief Medical Officer

Promontory Therapeutics Inc. , a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, today announced the appointment of Johan Baeck, MD, as Executive Vice President and Chief Medical Officer.

May 16, 2022
·
3 min read
Business

CNS Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

CNS Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update.

May 16, 2022
·
8 min read
Accelerate Diagnostics announces commercialization of its Accelerate Arc™ system having completed IVD registration with FDA

Commercialization of Accelerate Arc system, which includes the Accelerate Arc Module and BC kit, unlocks the path to automated, rapid microbial ID for positive blood cultures across the large installed base of MALDI system users.

May 16, 2022
·
4 min read
Pharm Country

Iveric Bio to Participate in the H.C. Wainwright Global Investment Conference

IVERIC bio, Inc. announced that Pravin U. Dugel, M.D., President, will present a corporate overview at the H.C. Wainwright Global Investment Conference, being held from May 23-26, 2022.

May 16, 2022
·
2 min read
Business

ENDRA Life Sciences to Present at the H.C. Wainwright Global Investment Conference

ENDRA Life Sciences to Present at the H.C. Wainwright Global Investment Conference.

May 16, 2022
·
1 min read
Alvotech Announces Positive Results from a Pharmacokinetic Similarity Study for AVT04, a Proposed Biosimilar to Stelara®

Alvotech Holdings S.A. today announced positive top-line results from a pharmacokinetic (PK) study for AVT04, Alvotech’s proposed biosimilar to to Stelara® (ustekinumab).

May 16, 2022
·
13 min read
Genetown

PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing

PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced the availability of ultrarapid whole genome sequencing (urWGS) through PerkinElmer Genomics.

May 16, 2022
·
3 min read
Drug Development

Catamaran Bio Presents Preclinical Data Supporting Novel Engineered CAR-NK Cell Therapies For Treating Solid Tumors

Catamaran Bio , Inc., a biotechnology company developing off-the-shelf chimeric antigen receptor (CAR)-NK cell therapies to treat cancer, is presenting new preclinical data today at the American Society of Gene and Cell Therapy.

May 16, 2022
·
3 min read
Business

Avilar Therapeutics Announces Formation of Scientific Advisory Board With Leading Experts in Protein Degradation, Chemistry, Genetics, and Drug Discovery

Avilar Therapeutics , a biopharmaceutical company focused on extracellular protein degradation, today announced the formation of its Scientific Advisory Board (SAB) comprised of an esteemed group of leading scientists with expertise in protein degradation, chemistry, genetics, and drug discovery.

May 16, 2022
·
6 min read